Program Purpose Statement
The purpose of the second-year pharmacy residency program in Thrombosis and Hemostasis Management is to provide advanced training and clinical expertise to licensed pharmacists with a PGY1 residency in the specialized field of anticoagulation and hemostasis. This program equips residents with the skills and knowledge needed for excellence in various clinical roles, including inpatient and outpatient anticoagulation management, anticoagulation and hemostasis consultation services, and active participation in anticoagulation stewardship programs. Upon successful completion of the PGY2 pharmacy residency, residents will be expected to demonstrate the competencies required to contribute effectively to patient care, optimize anticoagulation therapy, and advance the field of thrombosis and hemostasis management.
Residency Goals
The PGY2 Thrombosis and Hemostasis pharmacy residency program builds on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists with a specialty in thrombosis and hemostasis management. Residents who successfully complete the PGY2 thrombosis and hemostasis pharmacy residency are prepared for advanced patient care, academic, or other specialized positions.
- Clinical Expertise: Develop advanced clinical knowledge and expertise in thrombosis and hemostasis management.
- Patient Care: Provide direct patient care services related to anticoagulation and treatment of thrombosis and bleeding, optimizing therapy, and ensuring patient safety.
- Interdisciplinary Collaboration: Collaborate effectively with healthcare professionals to enhance patient outcomes and contribute to a comprehensive approach to patient care.
- Medication Management: Optimize medication therapy by actively participating in anticoagulation dosing and monitoring, including adjusting doses as needed.
- Education and Training: Engage in educating healthcare professionals, patients, and caregivers concerning thrombosis and hemostasis management.
- Research and Scholarly Activity: Contribute to the advancement of knowledge in the field through research and scholarly activities, including presentations and publications.
- Board Certification: If desired, prepare for and achieve board certification in thrombosis and hemostasis management areas.
Training Site
The Hospital of the University of Pennsylvania (HUP) is a robust 988-bed hospital with a wide range of specialties actively involved in thrombosis and hemostasis management, including cardiovascular medicine, interventional cardiology, hematology, interventional vascular radiology, pulmonary embolism response team, and the vascular neurology program. Within the hospital, the Anticoagulation Inpatient Management (AIM) team plays a crucial role in collaborating with other healthcare providers and serves as an invaluable source on anticoagulants and their reversals.
Additionally, the outpatient Anticoagulation Management Center (AMC), which oversees the ambulatory anticoagulation needs of over 1400 patients yearly, operates as a multidisciplinary unit. This team includes nurse practitioners, pharmacists, clinicians, practicing nurses, and administrative staff working together to provide comprehensive anticoagulation care. In the outpatient clinic, patients receive personalized care through on-site point-of-care testing and telephone-based management for remote INR monitoring. The AMC coordinates with other ambulatory physicians to deliver safe and effective care for patients who require interruptions of therapy, changes to the duration of therapy, or transitions between anticoagulants.
The HUP Pharmacy Department is one of four recipients of the Anticoagulation Forum TRAIN Grant for PGY2 Thrombosis and Hemostasis Residents in 2024-2025 and 2025-2026.
Learning Experiences
Required Rotations (four weeks)
- Orientation
- Coagulation Laboratory
- Benign Hematology
- Ambulatory Anticoagulation (AMC)
- Inpatient Anticoagulation (AIM)
- Cardiology ICU
- Heart and Vascular ICU
- Medication Safety
- Neurosciences ICU
- Pediatric Thrombosis
Elective Rotations (four weeks)
- Repeat of any required rotation
- Inpatient Hepatology
- Outpatient Cardiology / VAD Clinic
Longitudinal Activities
- Clinical On-Call
- AIM team
- Medication Use Evaluation
- Research Project
- Anticoagulation Subcommittee
- Medication Safety Subcommittee
- Biweekly topic series with other ASHP hematology residents
- Staffing (CICU/Cards)
- Therapeutics Conference
- Grand Rounds
- Journal Clubs
Additional Activities
- Precept pharmacy students, PGY1 residents, and other healthcare providers
- Prepare to undertake the Certified Anticoagulation Care Provider (CACP) examination
- Represent the AIM and AMC services at pharmacy department meetings
- Optional completion of ASHP Anticoagulation Certificate Program
Residency Program Director
Pardis Niami, PharmD, CACP
Clinical Pharmacy Specialist, Anticoagulation Inpatient Management
Hospital of the University of Pennsylvania
Department of Pharmacy
3400 Spruce Street | Philadelphia, PA 19104
Email: Pardis.Niami@pennmedicine.upenn.edu
Residency Program Coordinator
Sophia Pathan, PharmD, BCPS, BCCCP
Clinical Pharmacist, Neurocritical Care
Hospital of the University of Pennsylvania
3400 Spruce Street | Philadelphia, PA 19104
Email: Sophia.Pathan@pennmedicine.upenn.edu
Application Requirements
Candidates interested in the program should apply through the Pharmacy Online Residency Centralized Application Service (PhORCAS).
- Academic transcripts from your School of Pharmacy
- Letter of Intent which addresses the following:
- Why you have chosen the Hospital of the University of Pennsylvania
- Why you have chosen to pursue specialized training in thrombosis and hemostasis management
- Your residency and career goals
- Curriculum vitae
- Three letters of recommendation should be submitted through the PhORCAS system from the following:
- Two residency clinical rotation preceptors
- PGY1 Residency Program Director
All required application materials should be submitted to PhORCAS by January 3rd.
All residents are required to obtain a Pennsylvania State Pharmacy License by October 1st.